ARTICLE | Financial News
BioBlast Pharma withdraws follow-on
April 13, 2017 11:12 PM UTC
Rare disease play BioBlast Pharma Ltd. (NASDAQ:ORPN) withdrew its follow-on underwritten by H.C. Wainwright on April 6, citing market conditions. In February, the company proposed to raise up to $11....
BCIQ Company Profiles